- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Microneedles for Trans & Intradermal Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Microneedles for Trans & Intradermal Drug Delivery market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Drugs accounting for % of the Microneedles for Trans & Intradermal Drug Delivery global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Solid Microneedles segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Microneedles for Trans & Intradermal Drug Delivery include Becton Dickinson, Nanopass Technologies, Radius Health, Clearside Biomedical, and Dr. Prausnitz Group, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Microneedles for Trans & Intradermal Drug Delivery market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Solid Microneedles
Hollow Microneedles
Dissolvable Microneedles
Market segment by Application can be divided into
Drugs
Vaccines
Proteins
Peptides
Others
The key market players for global Microneedles for Trans & Intradermal Drug Delivery market are listed below:
Becton Dickinson
Nanopass Technologies
Radius Health
Clearside Biomedical
Dr. Prausnitz Group
Zosano Pharma
Corium International
Circassia
Valeritas, Inc.
BD Medical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Microneedles for Trans & Intradermal Drug Delivery product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Microneedles for Trans & Intradermal Drug Delivery, with price, sales, revenue and global market share of Microneedles for Trans & Intradermal Drug Delivery from 2019 to 2022.
Chapter 3, the Microneedles for Trans & Intradermal Drug Delivery competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Microneedles for Trans & Intradermal Drug Delivery breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Microneedles for Trans & Intradermal Drug Delivery market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Microneedles for Trans & Intradermal Drug Delivery.
Chapter 13, 14, and 15, to describe Microneedles for Trans & Intradermal Drug Delivery sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Microneedles for Trans & Intradermal Drug Delivery Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Solid Microneedles
1.2.3 Hollow Microneedles
1.2.4 Dissolvable Microneedles
1.3 Market Analysis by Application
1.3.1 Overview: Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Drugs
1.3.3 Vaccines
1.3.4 Proteins
1.3.5 Peptides
1.3.6 Others
1.4 Global Microneedles for Trans & Intradermal Drug Delivery Market Size & Forecast
1.4.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales in Volume (2017-2028)
1.4.3 Global Microneedles for Trans & Intradermal Drug Delivery Price (2017-2028)
1.5 Global Microneedles for Trans & Intradermal Drug Delivery Production Capacity Analysis
1.5.1 Global Microneedles for Trans & Intradermal Drug Delivery Total Production Capacity (2017-2028)
1.5.2 Global Microneedles for Trans & Intradermal Drug Delivery Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Microneedles for Trans & Intradermal Drug Delivery Market Drivers
1.6.2 Microneedles for Trans & Intradermal Drug Delivery Market Restraints
1.6.3 Microneedles for Trans & Intradermal Drug Delivery Trends Analysis
2 Manufacturers Profiles
2.1 Becton Dickinson
2.1.1 Becton Dickinson Details
2.1.2 Becton Dickinson Major Business
2.1.3 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Product and Services
2.1.4 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Nanopass Technologies
2.2.1 Nanopass Technologies Details
2.2.2 Nanopass Technologies Major Business
2.2.3 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Product and Services
2.2.4 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Radius Health
2.3.1 Radius Health Details
2.3.2 Radius Health Major Business
2.3.3 Radius Health Microneedles for Trans & Intradermal Drug Delivery Product and Services
2.3.4 Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Clearside Biomedical
2.4.1 Clearside Biomedical Details
2.4.2 Clearside Biomedical Major Business
2.4.3 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Product and Services
2.4.4 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Dr. Prausnitz Group
2.5.1 Dr. Prausnitz Group Details
2.5.2 Dr. Prausnitz Group Major Business
2.5.3 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Product and Services
2.5.4 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Zosano Pharma
2.6.1 Zosano Pharma Details
2.6.2 Zosano Pharma Major Business
2.6.3 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Product and Services
2.6.4 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Corium International
2.7.1 Corium International Details
2.7.2 Corium International Major Business
2.7.3 Corium International Microneedles for Trans & Intradermal Drug Delivery Product and Services
2.7.4 Corium International Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Circassia
2.8.1 Circassia Details
2.8.2 Circassia Major Business
2.8.3 Circassia Microneedles for Trans & Intradermal Drug Delivery Product and Services
2.8.4 Circassia Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Valeritas, Inc.
2.9.1 Valeritas, Inc. Details
2.9.2 Valeritas, Inc. Major Business
2.9.3 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Product and Services
2.9.4 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 BD Medical
2.10.1 BD Medical Details
2.10.2 BD Medical Major Business
2.10.3 BD Medical Microneedles for Trans & Intradermal Drug Delivery Product and Services
2.10.4 BD Medical Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Microneedles for Trans & Intradermal Drug Delivery Breakdown Data by Manufacturer
3.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Microneedles for Trans & Intradermal Drug Delivery
3.4 Market Concentration Rate
3.4.1 Top 3 Microneedles for Trans & Intradermal Drug Delivery Manufacturer Market Share in 2021
3.4.2 Top 6 Microneedles for Trans & Intradermal Drug Delivery Manufacturer Market Share in 2021
3.5 Global Microneedles for Trans & Intradermal Drug Delivery Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Microneedles for Trans & Intradermal Drug Delivery Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Microneedles for Trans & Intradermal Drug Delivery Market Size by Region
4.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales in Volume by Region (2017-2028)
4.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2017-2028)
4.2 North America Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028)
4.3 Europe Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028)
4.4 Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028)
4.5 South America Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028)
4.6 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales in Volume by Type (2017-2028)
5.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2028)
5.3 Global Microneedles for Trans & Intradermal Drug Delivery Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales in Volume by Application (2017-2028)
6.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2028)
6.3 Global Microneedles for Trans & Intradermal Drug Delivery Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2028)
7.2 North America Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2028)
7.3 North America Microneedles for Trans & Intradermal Drug Delivery Market Size by Country
7.3.1 North America Microneedles for Trans & Intradermal Drug Delivery Sales in Volume by Country (2017-2028)
7.3.2 North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2028)
8.2 Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2028)
8.3 Europe Microneedles for Trans & Intradermal Drug Delivery Market Size by Country
8.3.1 Europe Microneedles for Trans & Intradermal Drug Delivery Sales in Volume by Country (2017-2028)
8.3.2 Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2028)
9.2 Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2028)
9.3 Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Market Size by Region
9.3.1 Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2028)
10.2 South America Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2028)
10.3 South America Microneedles for Trans & Intradermal Drug Delivery Market Size by Country
10.3.1 South America Microneedles for Trans & Intradermal Drug Delivery Sales in Volume by Country (2017-2028)
10.3.2 South America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2028)
11.2 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2028)
11.3 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Market Size by Country
11.3.1 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Microneedles for Trans & Intradermal Drug Delivery and Key Manufacturers
12.2 Manufacturing Costs Percentage of Microneedles for Trans & Intradermal Drug Delivery
12.3 Microneedles for Trans & Intradermal Drug Delivery Production Process
12.4 Microneedles for Trans & Intradermal Drug Delivery Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Microneedles for Trans & Intradermal Drug Delivery Typical Distributors
13.3 Microneedles for Trans & Intradermal Drug Delivery Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Becton Dickinson Basic Information, Manufacturing Base and Competitors
Table 4. Becton Dickinson Major Business
Table 5. Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Product and Services
Table 6. Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Nanopass Technologies Basic Information, Manufacturing Base and Competitors
Table 8. Nanopass Technologies Major Business
Table 9. Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Product and Services
Table 10. Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Radius Health Basic Information, Manufacturing Base and Competitors
Table 12. Radius Health Major Business
Table 13. Radius Health Microneedles for Trans & Intradermal Drug Delivery Product and Services
Table 14. Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Clearside Biomedical Basic Information, Manufacturing Base and Competitors
Table 16. Clearside Biomedical Major Business
Table 17. Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Product and Services
Table 18. Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Dr. Prausnitz Group Basic Information, Manufacturing Base and Competitors
Table 20. Dr. Prausnitz Group Major Business
Table 21. Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Product and Services
Table 22. Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Zosano Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Zosano Pharma Major Business
Table 25. Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Product and Services
Table 26. Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Corium International Basic Information, Manufacturing Base and Competitors
Table 28. Corium International Major Business
Table 29. Corium International Microneedles for Trans & Intradermal Drug Delivery Product and Services
Table 30. Corium International Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Circassia Basic Information, Manufacturing Base and Competitors
Table 32. Circassia Major Business
Table 33. Circassia Microneedles for Trans & Intradermal Drug Delivery Product and Services
Table 34. Circassia Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Valeritas, Inc. Basic Information, Manufacturing Base and Competitors
Table 36. Valeritas, Inc. Major Business
Table 37. Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Product and Services
Table 38. Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. BD Medical Basic Information, Manufacturing Base and Competitors
Table 40. BD Medical Major Business
Table 41. BD Medical Microneedles for Trans & Intradermal Drug Delivery Product and Services
Table 42. BD Medical Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Microneedles for Trans & Intradermal Drug Delivery, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Microneedles for Trans & Intradermal Drug Delivery Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Microneedles for Trans & Intradermal Drug Delivery Production Site of Key Manufacturer
Table 48. Microneedles for Trans & Intradermal Drug Delivery New Entrant and Capacity Expansion Plans
Table 49. Microneedles for Trans & Intradermal Drug Delivery Mergers & Acquisitions in the Past Five Years
Table 50. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2017-2022) & (K Units)
Table 51. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2023-2028) & (K Units)
Table 52. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 55. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 56. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Microneedles for Trans & Intradermal Drug Delivery Price by Type (2017-2022) & (USD/Unit)
Table 59. Global Microneedles for Trans & Intradermal Drug Delivery Price by Type (2023-2028) & (USD/Unit)
Table 60. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 61. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 62. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Microneedles for Trans & Intradermal Drug Delivery Price by Application (2017-2022) & (USD/Unit)
Table 65. Global Microneedles for Trans & Intradermal Drug Delivery Price by Application (2023-2028) & (USD/Unit)
Table 66. North America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 67. North America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2023-2028) & (K Units)
Table 68. North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 71. North America Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 72. North America Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 73. North America Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 74. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 75. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2023-2028) & (K Units)
Table 76. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 79. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 80. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 81. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 90. South America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 91. South America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2023-2028) & (K Units)
Table 92. South America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 95. South America Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 96. South America Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 97. South America Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 106. Microneedles for Trans & Intradermal Drug Delivery Raw Material
Table 107. Key Manufacturers of Microneedles for Trans & Intradermal Drug Delivery Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Microneedles for Trans & Intradermal Drug Delivery Typical Distributors
Table 111. Microneedles for Trans & Intradermal Drug Delivery Typical Customers
List of Figures
Figure 1. Microneedles for Trans & Intradermal Drug Delivery Picture
Figure 2. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type in 2021
Figure 3. Solid Microneedles
Figure 4. Hollow Microneedles
Figure 5. Dissolvable Microneedles
Figure 6. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application in 2021
Figure 7. Drugs
Figure 8. Vaccines
Figure 9. Proteins
Figure 10. Peptides
Figure 11. Others
Figure 12. Global Microneedles for Trans & Intradermal Drug Delivery Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Microneedles for Trans & Intradermal Drug Delivery Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Microneedles for Trans & Intradermal Drug Delivery Sales (2017-2028) & (K Units)
Figure 15. Global Microneedles for Trans & Intradermal Drug Delivery Price (2017-2028) & (USD/Unit)
Figure 16. Global Microneedles for Trans & Intradermal Drug Delivery Production Capacity (2017-2028) & (K Units)
Figure 17. Global Microneedles for Trans & Intradermal Drug Delivery Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Microneedles for Trans & Intradermal Drug Delivery Market Drivers
Figure 19. Microneedles for Trans & Intradermal Drug Delivery Market Restraints
Figure 20. Microneedles for Trans & Intradermal Drug Delivery Market Trends
Figure 21. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Manufacturer in 2021
Figure 22. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Manufacturer in 2021
Figure 23. Microneedles for Trans & Intradermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Microneedles for Trans & Intradermal Drug Delivery Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Microneedles for Trans & Intradermal Drug Delivery Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Region (2017-2028)
Figure 27. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Region (2017-2028)
Figure 28. North America Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (USD Million)
Figure 29. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (USD Million)
Figure 31. South America Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (USD Million)
Figure 33. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2028)
Figure 34. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 35. Global Microneedles for Trans & Intradermal Drug Delivery Price by Type (2017-2028) & (USD/Unit)
Figure 36. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2028)
Figure 37. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 38. Global Microneedles for Trans & Intradermal Drug Delivery Price by Application (2017-2028) & (USD/Unit)
Figure 39. North America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2028)
Figure 40. North America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2028)
Figure 41. North America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country (2017-2028)
Figure 42. North America Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country (2017-2028)
Figure 43. United States Microneedles for Trans & Intradermal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Microneedles for Trans & Intradermal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Microneedles for Trans & Intradermal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2028)
Figure 47. Europe Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2028)
Figure 48. Europe Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country (2017-2028)
Figure 49. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country (2017-2028)
Figure 50. Germany Microneedles for Trans & Intradermal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Microneedles for Trans & Intradermal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Microneedles for Trans & Intradermal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Microneedles for Trans & Intradermal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Microneedles for Trans & Intradermal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Region (2017-2028)
Figure 59. China Microneedles for Trans & Intradermal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Microneedles for Trans & Intradermal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Microneedles for Trans & Intradermal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Microneedles for Trans & Intradermal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Microneedles for Trans & Intradermal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Microneedles for Trans & Intradermal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2028)
Figure 66. South America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2028)
Figure 67. South America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country (2017-2028)
Figure 68. South America Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Microneedles for Trans & Intradermal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Microneedles for Trans & Intradermal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Microneedles for Trans & Intradermal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Microneedles for Trans & Intradermal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Microneedles for Trans & Intradermal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Microneedles for Trans & Intradermal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Microneedles for Trans & Intradermal Drug Delivery in 2021
Figure 80. Manufacturing Process Analysis of Microneedles for Trans & Intradermal Drug Delivery
Figure 81. Microneedles for Trans & Intradermal Drug Delivery Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
